Report Detail
Global Opioid Induced Constipation Drugs Sales Market Report 2021
- RnM3283179 |
- 23 April, 2021 |
- Global |
- 137 Pages |
- QYResearch |
- Other
The global Opioid Induced Constipation Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The Opioid Induced Constipation Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Opioid Induced Constipation Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
1 Opioid Induced Constipation Drugs Market Overview
- 1.1 Opioid Induced Constipation Drugs Product Scope
- 1.2 Opioid Induced Constipation Drugs Segment by Type
- 1.2.1 Global Opioid Induced Constipation Drugs Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Lubiprostone
- 1.2.3 Methyl Naltrexone Bromide
- 1.2.4 Naldemedine
- 1.2.5 Alvimopan
- 1.2.6 Others
- 1.3 Opioid Induced Constipation Drugs Segment by Application
- 1.3.1 Global Opioid Induced Constipation Drugs Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Online Pharmacies
- 1.4 Opioid Induced Constipation Drugs Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Opioid Induced Constipation Drugs Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Opioid Induced Constipation Drugs Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Opioid Induced Constipation Drugs Price Trends (2016-2027)
2 Opioid Induced Constipation Drugs Estimates and Forecasts by Region
- 2.1 Global Opioid Induced Constipation Drugs Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Opioid Induced Constipation Drugs Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Opioid Induced Constipation Drugs Sales Market Share by Region (2016-2021)
- 2.2.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Region (2016-2021)
- 2.3 Global Opioid Induced Constipation Drugs Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Opioid Induced Constipation Drugs Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Opioid Induced Constipation Drugs Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Opioid Induced Constipation Drugs Estimates and Projections (2016-2027)
- 2.4.2 Europe Opioid Induced Constipation Drugs Estimates and Projections (2016-2027)
- 2.4.3 China Opioid Induced Constipation Drugs Estimates and Projections (2016-2027)
- 2.4.4 Japan Opioid Induced Constipation Drugs Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Opioid Induced Constipation Drugs Estimates and Projections (2016-2027)
- 2.4.6 India Opioid Induced Constipation Drugs Estimates and Projections (2016-2027)
3 Global Opioid Induced Constipation Drugs Competition Landscape by Players
- 3.1 Global Top Opioid Induced Constipation Drugs Players by Sales (2016-2021)
- 3.2 Global Top Opioid Induced Constipation Drugs Players by Revenue (2016-2021)
- 3.3 Global Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Induced Constipation Drugs as of 2020)
- 3.4 Global Opioid Induced Constipation Drugs Average Price by Company (2016-2021)
- 3.5 Manufacturers Opioid Induced Constipation Drugs Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Opioid Induced Constipation Drugs Market Size by Type
- 4.1 Global Opioid Induced Constipation Drugs Historic Market Review by Type (2016-2021)
- 4.1.1 Global Opioid Induced Constipation Drugs Sales Market Share by Type (2016-2021)
- 4.1.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Opioid Induced Constipation Drugs Price by Type (2016-2021)
- 4.2 Global Opioid Induced Constipation Drugs Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Opioid Induced Constipation Drugs Sales Forecast by Type (2022-2027)
- 4.2.2 Global Opioid Induced Constipation Drugs Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Opioid Induced Constipation Drugs Price Forecast by Type (2022-2027)
5 Global Opioid Induced Constipation Drugs Market Size by Application
- 5.1 Global Opioid Induced Constipation Drugs Historic Market Review by Application (2016-2021)
- 5.1.1 Global Opioid Induced Constipation Drugs Sales Market Share by Application (2016-2021)
- 5.1.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Opioid Induced Constipation Drugs Price by Application (2016-2021)
- 5.2 Global Opioid Induced Constipation Drugs Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Opioid Induced Constipation Drugs Sales Forecast by Application (2022-2027)
- 5.2.2 Global Opioid Induced Constipation Drugs Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Opioid Induced Constipation Drugs Price Forecast by Application (2022-2027)
6 North America Opioid Induced Constipation Drugs Market Facts & Figures
- 6.1 North America Opioid Induced Constipation Drugs Sales by Company
- 6.1.1 North America Opioid Induced Constipation Drugs Sales by Company (2016-2021)
- 6.1.2 North America Opioid Induced Constipation Drugs Revenue by Company (2016-2021)
- 6.2 North America Opioid Induced Constipation Drugs Sales Breakdown by Type
- 6.2.1 North America Opioid Induced Constipation Drugs Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Opioid Induced Constipation Drugs Sales Breakdown by Type (2022-2027)
- 6.3 North America Opioid Induced Constipation Drugs Sales Breakdown by Application
- 6.3.1 North America Opioid Induced Constipation Drugs Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Opioid Induced Constipation Drugs Sales Breakdown by Application (2022-2027)
7 Europe Opioid Induced Constipation Drugs Market Facts & Figures
- 7.1 Europe Opioid Induced Constipation Drugs Sales by Company
- 7.1.1 Europe Opioid Induced Constipation Drugs Sales by Company (2016-2021)
- 7.1.2 Europe Opioid Induced Constipation Drugs Revenue by Company (2016-2021)
- 7.2 Europe Opioid Induced Constipation Drugs Sales Breakdown by Type
- 7.2.1 Europe Opioid Induced Constipation Drugs Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Opioid Induced Constipation Drugs Sales Breakdown by Type (2022-2027)
- 7.3 Europe Opioid Induced Constipation Drugs Sales Breakdown by Application
- 7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Opioid Induced Constipation Drugs Market Facts & Figures
- 8.1 China Opioid Induced Constipation Drugs Sales by Company
- 8.1.1 China Opioid Induced Constipation Drugs Sales by Company (2016-2021)
- 8.1.2 China Opioid Induced Constipation Drugs Revenue by Company (2016-2021)
- 8.2 China Opioid Induced Constipation Drugs Sales Breakdown by Type
- 8.2.1 China Opioid Induced Constipation Drugs Sales Breakdown by Type (2016-2021)
- 8.2.2 China Opioid Induced Constipation Drugs Sales Breakdown by Type (2022-2027)
- 8.3 China Opioid Induced Constipation Drugs Sales Breakdown by Application
- 8.3.1 China 163 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 163 Sales Breakdown by Application (2022-2027)
9 Japan Opioid Induced Constipation Drugs Market Facts & Figures
- 9.1 Japan Opioid Induced Constipation Drugs Sales by Company
- 9.1.1 Japan Opioid Induced Constipation Drugs Sales by Company (2016-2021)
- 9.1.2 Japan Opioid Induced Constipation Drugs Revenue by Company (2016-2021)
- 9.2 Japan Opioid Induced Constipation Drugs Sales Breakdown by Type
- 9.2.1 Japan Opioid Induced Constipation Drugs Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Opioid Induced Constipation Drugs Sales Breakdown by Type (2022-2027)
- 9.3 Japan Opioid Induced Constipation Drugs Sales Breakdown by Application
- 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Opioid Induced Constipation Drugs Market Facts & Figures
- 10.1 Southeast Asia Opioid Induced Constipation Drugs Sales by Company
- 10.1.1 Southeast Asia Opioid Induced Constipation Drugs Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Opioid Induced Constipation Drugs Revenue by Company (2016-2021)
- 10.2 Southeast Asia Opioid Induced Constipation Drugs Sales Breakdown by Type
- 10.2.1 Southeast Asia Opioid Induced Constipation Drugs Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Opioid Induced Constipation Drugs Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Opioid Induced Constipation Drugs Sales Breakdown by Application
- 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Opioid Induced Constipation Drugs Market Facts & Figures
- 11.1 India Opioid Induced Constipation Drugs Sales by Company
- 11.1.1 India Opioid Induced Constipation Drugs Sales by Company (2016-2021)
- 11.1.2 India Opioid Induced Constipation Drugs Revenue by Company (2016-2021)
- 11.2 India Opioid Induced Constipation Drugs Sales Breakdown by Type
- 11.2.1 India Opioid Induced Constipation Drugs Sales Breakdown by Type (2016-2021)
- 11.2.2 India Opioid Induced Constipation Drugs Sales Breakdown by Type (2022-2027)
- 11.3 India Opioid Induced Constipation Drugs Sales Breakdown by Application
- 11.3.1 India Opioid Induced Constipation Drugs Sales Breakdown by Application (2016-2021)
- 11.3.2 India Opioid Induced Constipation Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Opioid Induced Constipation Drugs Business
- 12.1 Ironwood Pharmaceuticals Inc
- 12.1.1 Ironwood Pharmaceuticals Inc Corporation Information
- 12.1.2 Ironwood Pharmaceuticals Inc Business Overview
- 12.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Products Offered
- 12.1.5 Ironwood Pharmaceuticals Inc Recent Development
- 12.2 Daiichi Sankyo Co Ltd
- 12.2.1 Daiichi Sankyo Co Ltd Corporation Information
- 12.2.2 Daiichi Sankyo Co Ltd Business Overview
- 12.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Products Offered
- 12.2.5 Daiichi Sankyo Co Ltd Recent Development
- 12.3 Pfizer
- 12.3.1 Pfizer Corporation Information
- 12.3.2 Pfizer Business Overview
- 12.3.3 Pfizer Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Pfizer Opioid Induced Constipation Drugs Products Offered
- 12.3.5 Pfizer Recent Development
- 12.4 Progenics Pharmaceuticals Inc
- 12.4.1 Progenics Pharmaceuticals Inc Corporation Information
- 12.4.2 Progenics Pharmaceuticals Inc Business Overview
- 12.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Products Offered
- 12.4.5 Progenics Pharmaceuticals Inc Recent Development
- 12.5 Shionogi & Co., Ltd
- 12.5.1 Shionogi & Co., Ltd Corporation Information
- 12.5.2 Shionogi & Co., Ltd Business Overview
- 12.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Products Offered
- 12.5.5 Shionogi & Co., Ltd Recent Development
- 12.6 Allergan Plc
- 12.6.1 Allergan Plc Corporation Information
- 12.6.2 Allergan Plc Business Overview
- 12.6.3 Allergan Plc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Allergan Plc Opioid Induced Constipation Drugs Products Offered
- 12.6.5 Allergan Plc Recent Development
- 12.7 Nektar Therapeutics
- 12.7.1 Nektar Therapeutics Corporation Information
- 12.7.2 Nektar Therapeutics Business Overview
- 12.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Nektar Therapeutics Opioid Induced Constipation Drugs Products Offered
- 12.7.5 Nektar Therapeutics Recent Development
- 12.8 Purdue Pharma
- 12.8.1 Purdue Pharma Corporation Information
- 12.8.2 Purdue Pharma Business Overview
- 12.8.3 Purdue Pharma Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Purdue Pharma Opioid Induced Constipation Drugs Products Offered
- 12.8.5 Purdue Pharma Recent Development
- 12.9 S.L.A. Pharma AG
- 12.9.1 S.L.A. Pharma AG Corporation Information
- 12.9.2 S.L.A. Pharma AG Business Overview
- 12.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 S.L.A. Pharma AG Opioid Induced Constipation Drugs Products Offered
- 12.9.5 S.L.A. Pharma AG Recent Development
- 12.10 Mundipharma International Limited
- 12.10.1 Mundipharma International Limited Corporation Information
- 12.10.2 Mundipharma International Limited Business Overview
- 12.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Mundipharma International Limited Opioid Induced Constipation Drugs Products Offered
- 12.10.5 Mundipharma International Limited Recent Development
- 12.11 Ono Pharmaceutical Co., Ltd
- 12.11.1 Ono Pharmaceutical Co., Ltd Corporation Information
- 12.11.2 Ono Pharmaceutical Co., Ltd Business Overview
- 12.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Products Offered
- 12.11.5 Ono Pharmaceutical Co., Ltd Recent Development
- 12.12 Takeda Pharmaceutical Company Limited
- 12.12.1 Takeda Pharmaceutical Company Limited Corporation Information
- 12.12.2 Takeda Pharmaceutical Company Limited Business Overview
- 12.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Products Offered
- 12.12.5 Takeda Pharmaceutical Company Limited Recent Development
- 12.13 Theravance Biopharma Inc
- 12.13.1 Theravance Biopharma Inc Corporation Information
- 12.13.2 Theravance Biopharma Inc Business Overview
- 12.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.13.4 Theravance Biopharma Inc Opioid Induced Constipation Drugs Products Offered
- 12.13.5 Theravance Biopharma Inc Recent Development
- 12.14 Bausch Health
- 12.14.1 Bausch Health Corporation Information
- 12.14.2 Bausch Health Business Overview
- 12.14.3 Bausch Health Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.14.4 Bausch Health Opioid Induced Constipation Drugs Products Offered
- 12.14.5 Bausch Health Recent Development
- 12.15 Cosmo Pharmaceuticals SA
- 12.15.1 Cosmo Pharmaceuticals SA Corporation Information
- 12.15.2 Cosmo Pharmaceuticals SA Business Overview
- 12.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Products Offered
- 12.15.5 Cosmo Pharmaceuticals SA Recent Development
- 12.16 Daewoong Pharmaceutical
- 12.16.1 Daewoong Pharmaceutical Corporation Information
- 12.16.2 Daewoong Pharmaceutical Business Overview
- 12.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.16.4 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Products Offered
- 12.16.5 Daewoong Pharmaceutical Recent Development
- 12.17 C.B. Fleet Company
- 12.17.1 C.B. Fleet Company Corporation Information
- 12.17.2 C.B. Fleet Company Business Overview
- 12.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.17.4 C.B. Fleet Company Opioid Induced Constipation Drugs Products Offered
- 12.17.5 C.B. Fleet Company Recent Development
- 12.18 Sucampo Pharmaceuticals
- 12.18.1 Sucampo Pharmaceuticals Corporation Information
- 12.18.2 Sucampo Pharmaceuticals Business Overview
- 12.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2016-2021)
- 12.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Products Offered
- 12.18.5 Sucampo Pharmaceuticals Recent Development
13 Opioid Induced Constipation Drugs Manufacturing Cost Analysis
- 13.1 Opioid Induced Constipation Drugs Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Opioid Induced Constipation Drugs
- 13.4 Opioid Induced Constipation Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Opioid Induced Constipation Drugs Distributors List
- 14.3 Opioid Induced Constipation Drugs Customers
15 Market Dynamics
- 15.1 Opioid Induced Constipation Drugs Market Trends
- 15.2 Opioid Induced Constipation Drugs Drivers
- 15.3 Opioid Induced Constipation Drugs Market Challenges
- 15.4 Opioid Induced Constipation Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
Summary:
Get latest Market Research Reports on Opioid Induced Constipation Drugs . Industry analysis & Market Report on Opioid Induced Constipation Drugs is a syndicated market report, published as Global Opioid Induced Constipation Drugs Sales Market Report 2021. It is complete Research Study and Industry Analysis of Opioid Induced Constipation Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
